Serenova A/S: Financial statements 2012
CVR: 30532228
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
Serenova A/S (CVR 30532228) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -77,028 and a net result of DKK -333,378. Equity in the 2012 report amounted to DKK 10,274,071. The solvency ratio was 60.1%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -77,028
- Profit/Loss
- DKK -333,378
- Equity
- DKK 10,274,071
- Total Assets
- DKK 17,099,341
- Employees
- 2
Official annual report
Keep an eye on Serenova A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of August 21, 2012, Torsten Bjørn has joined the board of directors of Serenova A/S.
As of June 21, 2012, Eric Jean Marie Leire has left the board of directors of Serenova A/S.
As of June 21, 2012, Kaare Fiala has left the board of directors of Serenova A/S.
About Serenova A/S
Serenova A/S is a Danish company of the type Aktieselskab based in Solrød Strand, founded in 2008. The company is in liquidation. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named SERENDEX PHARMACEUTICALS A/S and SERENDEX A/S. The management consists of Michael Aslo-Petersen. The company is owned by Sorana Holding A/S. The company has 0 employees (2016). In 2025, the company reported a gross profit of DKK -167,993 and a net result of DKK 38,663,045 compared with DKK -24,273,688 the year before. Equity in the 2025 report amounted to DKK 105,405,408.